Abstract
This letter includes a case study, which shows the safety and efficacy of the intended use of Judkins guiding catheter for aspiration of excessive thrombus from the infarct‐related vein graft, which is however made off‐label. Guiding catheter thrombectomy offers optimal facilitation of primary angioplasty without device‐related delay in time‐to‐treatment. Consistently, the negative results of the EMERALD are related to the significantly longer door‐to‐balloon time while use of the dedicated but complex devices. Interestingly, the current report is in line with the REMEDIA trial, demonstrating superior myocardial tissue reperfusion after the intracoronary thrombectomy in an unselected patient population treated with the dedicated but manual and of a large aspiration lumen catheters.